Melanoma: oncogenic drivers and the immune system

Advances and in-depth understanding of the biology of melanoma over the past 30 years have contributed to a change in the consideration of melanoma as one of the most therapy-resistant malignancies. The finding that oncogenic BRAF mutations drive tumor growth in up to 50% of melanomas led to a molec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Transl Med
Autores principales: Karachaliou, Niki, Pilotto, Sara, Teixidó, Cristina, Viteri, Santiago, González-Cao, María, Riso, Aldo, Morales-Espinosa, Daniela, Molina, Miguel Angel, Chaib, Imane, Santarpia, Mariacarmela, Richardet, Eduardo, Bria, Emilio, Rosell, Rafael
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2015
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4630557/
https://ncbi.nlm.nih.gov/pubmed/26605311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2305-5839.2015.08.06
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares